Psychoactive substance use in patients diagnosed with attention-deficit/hyperactivity disorder: an exploratory study
Attention-deficit/hyperactivity disorder (ADHD) was originally treated as a neurodevelopmental disorder that occurs mainly in children and tends to diminish or disappear with age, but we now know that symptoms persist into adulthood in over 50% of ADHD patients. Undiagnosed individuals often turn to...
Saved in:
| Published in | Frontiers in psychiatry Vol. 14; p. 1184023 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Switzerland
Frontiers Media S.A
11.07.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Attention-deficit/hyperactivity disorder (ADHD) was originally treated as a neurodevelopmental disorder that occurs mainly in children and tends to diminish or disappear with age, but we now know that symptoms persist into adulthood in over 50% of ADHD patients. Undiagnosed individuals often turn to psychoactive substance to minimize the negative aspects of functioning and improve quality of life.
The study was conducted online using random sampling through a Facebook group administered by physicians and targeted to patients diagnosed with ADHD. The study was naturalistic and exploratory, therefore no hypothesis was made. 438 correctly completed questionnaires were received. Analysis of the results showed that people with ADHD turn to psychoactive substances relatively frequently.
The most commonly used stimulants include alcohol, marijuana, 3,4-methylenedioxymethamphetamine (MDMA), amphetamine/methamphetamine, and psilocybin. In the study population, methylphenidate is the most commonly used drug among patients. After treatment with psychostimulants, the majority of respondents note a decrease in symptoms of hyperactivity disorder, especially in male patients.
It is necessary to perform proper diagnostics and actively look for ADHD symptoms in patients who tend to use psychoactive substances. |
|---|---|
| AbstractList | IntroductionAttention-deficit/hyperactivity disorder (ADHD) was originally treated as a neurodevelopmental disorder that occurs mainly in children and tends to diminish or disappear with age, but we now know that symptoms persist into adulthood in over 50% of ADHD patients. Undiagnosed individuals often turn to psychoactive substance to minimize the negative aspects of functioning and improve quality of life. MethodsThe study was conducted online using random sampling through a Facebook group administered by physicians and targeted to patients diagnosed with ADHD. The study was naturalistic and exploratory, therefore no hypothesis was made. 438 correctly completed questionnaires were received. Analysis of the results showed that people with ADHD turn to psychoactive substances relatively frequently. ResultsThe most commonly used stimulants include alcohol, marijuana, 3,4-methylenedioxymethamphetamine (MDMA), amphetamine/methamphetamine, and psilocybin. In the study population, methylphenidate is the most commonly used drug among patients. After treatment with psychostimulants, the majority of respondents note a decrease in symptoms of hyperactivity disorder, especially in male patients. ConclusionIt is necessary to perform proper diagnostics and actively look for ADHD symptoms in patients who tend to use psychoactive substances. Introduction Attention-deficit/hyperactivity disorder (ADHD) was originally treated as a neurodevelopmental disorder that occurs mainly in children and tends to diminish or disappear with age, but we now know that symptoms persist into adulthood in over 50% of ADHD patients. Undiagnosed individuals often turn to psychoactive substance to minimize the negative aspects of functioning and improve quality of life. Methods The study was conducted online using random sampling through a Facebook group administered by physicians and targeted to patients diagnosed with ADHD. The study was naturalistic and exploratory, therefore no hypothesis was made. 438 correctly completed questionnaires were received. Analysis of the results showed that people with ADHD turn to psychoactive substances relatively frequently. Results The most commonly used stimulants include alcohol, marijuana, 3,4-methylenedioxymethamphetamine (MDMA), amphetamine/methamphetamine, and psilocybin. In the study population, methylphenidate is the most commonly used drug among patients. After treatment with psychostimulants, the majority of respondents note a decrease in symptoms of hyperactivity disorder, especially in male patients. Conclusion It is necessary to perform proper diagnostics and actively look for ADHD symptoms in patients who tend to use psychoactive substances. Attention-deficit/hyperactivity disorder (ADHD) was originally treated as a neurodevelopmental disorder that occurs mainly in children and tends to diminish or disappear with age, but we now know that symptoms persist into adulthood in over 50% of ADHD patients. Undiagnosed individuals often turn to psychoactive substance to minimize the negative aspects of functioning and improve quality of life. The study was conducted online using random sampling through a Facebook group administered by physicians and targeted to patients diagnosed with ADHD. The study was naturalistic and exploratory, therefore no hypothesis was made. 438 correctly completed questionnaires were received. Analysis of the results showed that people with ADHD turn to psychoactive substances relatively frequently. The most commonly used stimulants include alcohol, marijuana, 3,4-methylenedioxymethamphetamine (MDMA), amphetamine/methamphetamine, and psilocybin. In the study population, methylphenidate is the most commonly used drug among patients. After treatment with psychostimulants, the majority of respondents note a decrease in symptoms of hyperactivity disorder, especially in male patients. It is necessary to perform proper diagnostics and actively look for ADHD symptoms in patients who tend to use psychoactive substances. |
| Author | Więckiewicz, Gniewko Stokłosa, Maciej Gorczyca, Piotr Gondek, Tomasz M Więckiewicz, Włodzimierz Stokłosa, Iga |
| AuthorAffiliation | 2 Department of Prosthodontics, Faculty of Dentistry, Wroclaw Medical University , Wroclaw , Poland 3 Iter Psychology Practices , Wroclaw , Poland 1 Department of Psychiatry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia , Katowice , Poland |
| AuthorAffiliation_xml | – name: 2 Department of Prosthodontics, Faculty of Dentistry, Wroclaw Medical University , Wroclaw , Poland – name: 1 Department of Psychiatry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia , Katowice , Poland – name: 3 Iter Psychology Practices , Wroclaw , Poland |
| Author_xml | – sequence: 1 givenname: Gniewko surname: Więckiewicz fullname: Więckiewicz, Gniewko organization: Department of Psychiatry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland – sequence: 2 givenname: Iga surname: Stokłosa fullname: Stokłosa, Iga organization: Department of Psychiatry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland – sequence: 3 givenname: Maciej surname: Stokłosa fullname: Stokłosa, Maciej organization: Department of Psychiatry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland – sequence: 4 givenname: Włodzimierz surname: Więckiewicz fullname: Więckiewicz, Włodzimierz organization: Department of Prosthodontics, Faculty of Dentistry, Wroclaw Medical University, Wroclaw, Poland – sequence: 5 givenname: Piotr surname: Gorczyca fullname: Gorczyca, Piotr organization: Department of Psychiatry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland – sequence: 6 givenname: Tomasz M surname: Gondek fullname: Gondek, Tomasz M organization: Iter Psychology Practices, Wroclaw, Poland |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37496681$$D View this record in MEDLINE/PubMed |
| BookMark | eNpVkU1v1DAQhi1URD_oH-CAcuSyW3_FsbkgVAGtVAkOcLYm9mTXVTYOtlPIvyfdXarWl7HG7_vMWO85ORnigIS8Y3QthDZX3ZjnsuaUizVjWi71FTljSskVVZKePLufksuc7-lyhDFC1W_IqWikUUqzM1J-5NltI7gSHrDKU5sLDA6rKWMVhmqEEnAoufIBNkPM6Ks_oWwrKGVphzisPHbBhXK1nUdMe0wo8yLPMXlMHysYKvw79jFBiWmucpn8_Ja87qDPeHmsF-TX1y8_r29Wd9-_3V5_vls5qUxZmRpbJaRT3DOsEUGzDjphuKOy7bgX3DtvXIet42ga6pBpTWvW1mZxMS0uyO2B6yPc2zGFHaTZRgh234hpYyGV4Hq00LRcdy2AobWEhhrXeAUodSe8htYtrE8H1ji1O_Ru-X6C_gX05csQtnYTHyyjQqna8IXw4UhI8feEudhdyA77HgaMU7ZcS0FFw6RapPwgdSnmnLB7msOofYzf7uO3j_HbY_yL6f3zDZ8s_8MW_wB4_bPa |
| CitedBy_id | crossref_primary_10_1111_jir_13087 |
| Cites_doi | 10.1192/j.eurpsy.2022.2341 10.1177/1060028018795703 10.1016/S2215-0366(20)30339-4 10.1038/mp.2016.74 10.1016/j.neubiorev.2021.07.010 10.1542/peds.2014-0179 10.4088/JCP.1107e28 10.1017/neu.2021.23 10.1001/jamapsychiatry.2013.1273 10.1080/10826084.2019.1657895 10.1038/s41380-018-0116-3 10.1037/a0027347 10.1016/j.neubiorev.2021.02.002 10.1371/journal.pone.0156614 10.1016/j.jpsychires.2020.11.021 10.1016/j.neubiorev.2021.01.022 10.1002/14651858.CD007813.pub3 10.1007/s00213-007-0996-4 10.1371/journal.pone.0277175 10.4088/jcp.0807e20 10.1177/00048674221106669 10.1177/0004867417714878 10.1159/000343485 10.1016/j.jaac.2017.05.004 10.1016/j.jaac.2015.12.010 10.1097/HRP.0000000000000122 10.2174/0929867326666190805153610 10.1016/S0140-6736(14)61684-6 10.1089/cap.2022.0016 10.3109/13651501.2016.1149197 10.1024/1422-4917/a000854 10.1542/peds.111.1.179 10.1089/cap.2016.0124 10.1007/s11845-013-0925-y 10.1176/appi.ajp.2018.18040369 10.1136/eb-2016-102415 10.1080/10826080500294858 10.3390/medicina59050908 10.1186/s12888-021-03547-x |
| ContentType | Journal Article |
| Copyright | Copyright © 2023 Więckiewicz, Stokłosa, Stokłosa, Więckiewicz, Gorczyca and Gondek. Copyright © 2023 Więckiewicz, Stokłosa, Stokłosa, Więckiewicz, Gorczyca and Gondek. 2023 Więckiewicz, Stokłosa, Stokłosa, Więckiewicz, Gorczyca and Gondek |
| Copyright_xml | – notice: Copyright © 2023 Więckiewicz, Stokłosa, Stokłosa, Więckiewicz, Gorczyca and Gondek. – notice: Copyright © 2023 Więckiewicz, Stokłosa, Stokłosa, Więckiewicz, Gorczyca and Gondek. 2023 Więckiewicz, Stokłosa, Stokłosa, Więckiewicz, Gorczyca and Gondek |
| DBID | NPM AAYXX CITATION 7X8 5PM DOA |
| DOI | 10.3389/fpsyt.2023.1184023 |
| DatabaseName | PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
| DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic CrossRef PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 1664-0640 |
| EndPage | 1184023 |
| ExternalDocumentID | oai_doaj_org_article_a7b28fbaa9054a709c7d6ae48f3d8abc 10_3389_fpsyt_2023_1184023 37496681 |
| Genre | Journal Article |
| GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD ABIVO ACGFO ACGFS ACXDI ADBBV ADRAZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV DIK EMOBN GROUPED_DOAJ GX1 HYE IAO IEA IHR IHW IPNFZ IPY KQ8 M48 M~E NPM O5R O5S OK1 PGMZT RIG RNS RPM AAYXX AFPKN CITATION 7X8 5PM |
| ID | FETCH-LOGICAL-c469t-95eb634c62d1e5eea81faf392c04bf2d32dcd9cfebc2e970ce188051b5934c183 |
| IEDL.DBID | RPM |
| ISSN | 1664-0640 |
| IngestDate | Tue Oct 22 15:16:06 EDT 2024 Tue Sep 17 21:30:39 EDT 2024 Thu Oct 24 22:52:40 EDT 2024 Thu Sep 26 16:02:12 EDT 2024 Wed Oct 16 00:38:13 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | ADHD psychoactive substance abuse addiction psychiatry psychoactive substance addiction |
| Language | English |
| License | Copyright © 2023 Więckiewicz, Stokłosa, Stokłosa, Więckiewicz, Gorczyca and Gondek. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c469t-95eb634c62d1e5eea81faf392c04bf2d32dcd9cfebc2e970ce188051b5934c183 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Carlos Roncero, University of Salamanca, Spain Reviewed by: Mario R. Louzã, University of São Paulo, Brazil; Matej Stuhec, University of Maribor, Slovenia |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366592/ |
| PMID | 37496681 |
| PQID | 2843037146 |
| PQPubID | 23479 |
| PageCount | 1 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_a7b28fbaa9054a709c7d6ae48f3d8abc pubmedcentral_primary_oai_pubmedcentral_nih_gov_10366592 proquest_miscellaneous_2843037146 crossref_primary_10_3389_fpsyt_2023_1184023 pubmed_primary_37496681 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-07-11 |
| PublicationDateYYYYMMDD | 2023-07-11 |
| PublicationDate_xml | – month: 07 year: 2023 text: 2023-07-11 day: 11 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Frontiers in psychiatry |
| PublicationTitleAlternate | Front Psychiatry |
| PublicationYear | 2023 |
| Publisher | Frontiers Media S.A |
| Publisher_xml | – name: Frontiers Media S.A |
| References | Humphreys (ref23) 2013; 70 Choi (ref8) 2022; 17 Rocco (ref37) 2021; 21 de Crescenzo (ref2) 2017; 20 Castells (ref6) 2018; 2018 Regan (ref38) 2020; 55 Groenman (ref20) 2017; 56 Döpfner (ref4) 2021; 128 Carpentier (ref11) 2017; 25 Luderer (ref10) 2021; 128 Ng (ref12) 2017; 27 Sanchez-Roige (ref35) 2019; 176 Bartoli (ref36) 2023; 57 Gundersen (ref19) 2013; 19 Faraone (ref24) 2007; 68 Zalsman (ref1) 2016; 20 Faraone (ref13) 2003; 64 Oliva (ref32) 2021; 143 Bonvicini (ref5) 2016; 21 Kiejna (ref39) 2023; 66 Mucci (ref34) 2019; 26 Willcutt (ref7) 2012; 121 Stuhec (ref27) 2013; 182 Schoenfelder (ref25) 2014; 133 Cook (ref26) 2017; 51 Johnson (ref31) 2020; 7 Więckiewicz (ref18) 2023; 59 Wilens (ref28) 2003; 111 Caye (ref21) 2019; 24 Stuhec (ref14) 2019; 53 di Lorenzo (ref3) 2021; 33 Peterson (ref22) 2008; 197 Mitchell (ref33) 2016; 11 Faraone (ref40) 2021; 128 Brunkhorst-Kanaan (ref29) 2021; 125 Ottosen (ref30) 2016; 55 Wilens (ref9) 2007; 68 Wilens (ref15) 2022; 32 Kalbag (ref16) 2005; 40 Dalsgaard (ref17) 2015; 385 |
| References_xml | – volume: 66 start-page: E2 year: 2023 ident: ref39 article-title: Mortality in people with mental disorders in Poland: a nationwide, register-based cohort study publication-title: Eur Psychiatry doi: 10.1192/j.eurpsy.2022.2341 contributor: fullname: Kiejna – volume: 53 start-page: 121 year: 2019 ident: ref14 article-title: Efficacy, acceptability, and tolerability of Lisdexamfetamine, mixed amphetamine salts, methylphenidate, and Modafinil in the treatment of attention-deficit hyperactivity disorder in adults: a systematic review and meta-analysis publication-title: Ann Pharmacother doi: 10.1177/1060028018795703 contributor: fullname: Stuhec – volume: 7 start-page: 1032 year: 2020 ident: ref31 article-title: A large-scale genome-wide association study meta-analysis of cannabis use disorder [published correction appears in lancet psychiatry. 2022;9(4):e12] publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(20)30339-4 contributor: fullname: Johnson – volume: 21 start-page: 872 year: 2016 ident: ref5 article-title: Attention-deficit hyperactivity disorder in adults: a systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies publication-title: Mol Psychiatry doi: 10.1038/mp.2016.74 contributor: fullname: Bonvicini – volume: 128 start-page: 648 year: 2021 ident: ref10 article-title: Alcohol use disorders and ADHD publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2021.07.010 contributor: fullname: Luderer – volume: 133 start-page: 1070 year: 2014 ident: ref25 article-title: Stimulant treatment of ADHD and cigarette smoking: a meta-analysis publication-title: Pediatrics doi: 10.1542/peds.2014-0179 contributor: fullname: Schoenfelder – volume: 68 start-page: e28 year: 2007 ident: ref24 article-title: Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion publication-title: J Clin Psychiatry doi: 10.4088/JCP.1107e28 contributor: fullname: Faraone – volume: 33 start-page: 283 year: 2021 ident: ref3 article-title: Children and adolescents with ADHD followed up to adulthood: a systematic review of long-term outcomes publication-title: Acta Neuropsychiatr doi: 10.1017/neu.2021.23 contributor: fullname: di Lorenzo – volume: 70 start-page: 740 year: 2013 ident: ref23 article-title: Stimulant medication and substance use outcomes: a meta-analysis publication-title: JAMA Psychiat doi: 10.1001/jamapsychiatry.2013.1273 contributor: fullname: Humphreys – volume: 55 start-page: 119 year: 2020 ident: ref38 article-title: Attention deficit hyperactivity disorder (ADHD) subtypes, co-occurring psychiatric symptoms and sexual risk behaviors among adolescents receiving substance abuse treatment publication-title: Subst Use Misuse doi: 10.1080/10826084.2019.1657895 contributor: fullname: Regan – volume: 24 start-page: 390 year: 2019 ident: ref21 article-title: Treatment strategies for ADHD: an evidence-based guide to select optimal treatment publication-title: Mol Psychiatry doi: 10.1038/s41380-018-0116-3 contributor: fullname: Caye – volume: 121 start-page: 991 year: 2012 ident: ref7 article-title: Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes publication-title: J Abnorm Psychol doi: 10.1037/a0027347 contributor: fullname: Willcutt – volume: 125 start-page: 582 year: 2021 ident: ref29 article-title: ADHD and accidents over the life span – a systematic review publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2021.02.002 contributor: fullname: Brunkhorst-Kanaan – volume: 11 start-page: e0156614 year: 2016 ident: ref33 article-title: I use weed for my ADHD: a qualitative analysis of online forum discussions on Cannabis use and ADHD publication-title: PLoS One doi: 10.1371/journal.pone.0156614 contributor: fullname: Mitchell – volume: 143 start-page: 587 year: 2021 ident: ref32 article-title: Prevalence of cocaine use and cocaine use disorder among adult patients with attention-deficit/hyperactivity disorder: a systematic review and meta-analysis publication-title: J Psychiatr Res doi: 10.1016/j.jpsychires.2020.11.021 contributor: fullname: Oliva – volume: 128 start-page: 789 year: 2021 ident: ref40 article-title: The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2021.01.022 contributor: fullname: Faraone – volume: 2018 start-page: CD007813 year: 2018 ident: ref6 article-title: Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD007813.pub3 contributor: fullname: Castells – volume: 197 start-page: 1 year: 2008 ident: ref22 article-title: Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis publication-title: Psychopharmacology doi: 10.1007/s00213-007-0996-4 contributor: fullname: Peterson – volume: 17 start-page: e0277175 year: 2022 ident: ref8 article-title: The prevalence of psychiatric comorbidities in adult ADHD compared with non-ADHD populations: a systematic literature review publication-title: PLoS One doi: 10.1371/journal.pone.0277175 contributor: fullname: Choi – volume: 68 start-page: e20 year: 2007 ident: ref9 article-title: Impact of substance use disorder on ADHD and its treatment publication-title: J Clin Psychiatry doi: 10.4088/jcp.0807e20 contributor: fullname: Wilens – volume: 57 start-page: 34 year: 2023 ident: ref36 article-title: Clinical correlates of comorbid attention deficit hyperactivity disorder in adults suffering from bipolar disorder: a meta-analysis publication-title: Aust N Z J Psychiatry doi: 10.1177/00048674221106669 contributor: fullname: Bartoli – volume: 51 start-page: 876 year: 2017 ident: ref26 article-title: Managing attention deficit hyperactivity disorder in adults using illicit psychostimulants: a systematic review publication-title: Aust N Z J Psychiatry doi: 10.1177/0004867417714878 contributor: fullname: Cook – volume: 19 start-page: 252 year: 2013 ident: ref19 article-title: Evaluation of the alcohol use disorders identification test and the drug use disorders identification test among patients at a Norwegian psychiatric emergency ward publication-title: Eur Addict Res doi: 10.1159/000343485 contributor: fullname: Gundersen – volume: 56 start-page: 556 year: 2017 ident: ref20 article-title: Childhood psychiatric disorders as risk factor for subsequent substance abuse: a meta-analysis publication-title: J Am Acad Child Adolesc Psychiatry doi: 10.1016/j.jaac.2017.05.004 contributor: fullname: Groenman – volume: 55 start-page: 227 year: 2016 ident: ref30 article-title: Gender differences in associations between attention-deficit/hyperactivity disorder and substance use disorder publication-title: J Am Acad Child Adolesc Psychiatry doi: 10.1016/j.jaac.2015.12.010 contributor: fullname: Ottosen – volume: 25 start-page: 50 year: 2017 ident: ref11 article-title: Pharmacological treatment of ADHD in addicted patients: what does the literature tell us? publication-title: Harv Rev Psychiatry doi: 10.1097/HRP.0000000000000122 contributor: fullname: Carpentier – volume: 26 start-page: 6942 year: 2019 ident: ref34 article-title: ADHD with comorbid bipolar disorders: a systematic review of neurobiological, clinical and pharmacological aspects across the lifespan publication-title: Curr Med Chem doi: 10.2174/0929867326666190805153610 contributor: fullname: Mucci – volume: 64 start-page: 9 year: 2003 ident: ref13 article-title: Does stimulant treatment lead to substance use disorders? publication-title: J Clin Psychiatry contributor: fullname: Faraone – volume: 385 start-page: 2190 year: 2015 ident: ref17 article-title: Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study publication-title: Lancet doi: 10.1016/S0140-6736(14)61684-6 contributor: fullname: Dalsgaard – volume: 32 start-page: 200 year: 2022 ident: ref15 article-title: The impact of pharmacotherapy of childhood-onset psychiatric disorders on the development of substance use disorders publication-title: J Child Adolesc Psychopharmacol doi: 10.1089/cap.2022.0016 contributor: fullname: Wilens – volume: 20 start-page: 70 year: 2016 ident: ref1 article-title: Adult ADHD: a new disease? publication-title: Int J Psychiatry Clin Pract doi: 10.3109/13651501.2016.1149197 contributor: fullname: Zalsman – volume: 128 start-page: 789 year: 2021 ident: ref4 article-title: Klassifikation von Aufmerksamkeitsdefizit-/Hyperaktivitätsstörungen in der ICD-11 [classification of attention deficit-/hyperactivity disorder in ICD-11] publication-title: Z Kinder Jugendpsychiatr Psychother doi: 10.1024/1422-4917/a000854 contributor: fullname: Döpfner – volume: 111 start-page: 179 year: 2003 ident: ref28 article-title: Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature publication-title: Pediatrics doi: 10.1542/peds.111.1.179 contributor: fullname: Wilens – volume: 27 start-page: 112 year: 2017 ident: ref12 article-title: A systematic review of the use of bupropion for attention-deficit/hyperactivity disorder in children and adolescents publication-title: J Child Adolesc Psychopharmacol doi: 10.1089/cap.2016.0124 contributor: fullname: Ng – volume: 182 start-page: 535 year: 2013 ident: ref27 article-title: Atomoxetine-induced life-threatening long QT syndrome publication-title: Ir J Med Sci doi: 10.1007/s11845-013-0925-y contributor: fullname: Stuhec – volume: 176 start-page: 107 year: 2019 ident: ref35 article-title: Genome-wide association study Meta-analysis of the alcohol use disorders identification test (AUDIT) in two population-based cohorts publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2018.18040369 contributor: fullname: Sanchez-Roige – volume: 20 start-page: 4 year: 2017 ident: ref2 article-title: Pharmacological and non-pharmacological treatment of adults with ADHD: a meta-review publication-title: Evid Based Ment Health doi: 10.1136/eb-2016-102415 contributor: fullname: de Crescenzo – volume: 40 start-page: 1955 year: 2005 ident: ref16 article-title: Adult ADHD and substance abuse: diagnostic and treatment issues publication-title: Subst Use Misuse doi: 10.1080/10826080500294858 contributor: fullname: Kalbag – volume: 59 start-page: 908 year: 2023 ident: ref18 article-title: The need for psychiatric treatment among polish users of psychoactive substances is increasing: this and other results from the newest PolDrugs survey publication-title: Medicina (Kaunas) doi: 10.3390/medicina59050908 contributor: fullname: Więckiewicz – volume: 21 start-page: 575 year: 2021 ident: ref37 article-title: Time of onset and/or diagnosis of ADHD in European children: a systematic review publication-title: BMC Psychiatry doi: 10.1186/s12888-021-03547-x contributor: fullname: Rocco |
| SSID | ssj0000399365 |
| Score | 2.3600922 |
| Snippet | Attention-deficit/hyperactivity disorder (ADHD) was originally treated as a neurodevelopmental disorder that occurs mainly in children and tends to diminish or... Introduction Attention-deficit/hyperactivity disorder (ADHD) was originally treated as a neurodevelopmental disorder that occurs mainly in children and tends... IntroductionAttention-deficit/hyperactivity disorder (ADHD) was originally treated as a neurodevelopmental disorder that occurs mainly in children and tends to... |
| SourceID | doaj pubmedcentral proquest crossref pubmed |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database |
| StartPage | 1184023 |
| SubjectTerms | addiction addiction psychiatry ADHD Psychiatry psychoactive substance psychoactive substance abuse |
| SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3PSx0xEA7iqZdisa3b1hKhN1neJrvJJr1pUURoTwreQn5M0Msq3X0H_3tnsqu8J4VevC37M3yzmZkvmXxh7EfM2cvgfd1pk-tOeqi9wiOS_hA6i9SUqsrff_TFdXd5o242tvqimrBZHngGbuX7IE3Gt1lMLnzf2Ngn7aEzuU3Gh1i8b2M3yFTxwRR3tZpXySALs6v8MD5S7aRs0Usgq5HtViQqgv3_yjJfF0tuRJ_zPfZ-SRv5ydzcD2wHhn02zd7LF5fFR3QBE9mQr0fgdwNfJFNHnuZyOkicRl05KWqWGsc6AelHTKtbJKNltRRtJMHTIsj5k_uBQ6nRK1PxvEjRfmTX52dXvy7qZReFOiL1nWqrIOi2i1omAQrAG5F9xrQoNl3IMrUyxWRjhhAl2L6JQBJtSgRl8Sns8Z_Y7nA_wAHjRJ6C1QJfIbpMk7ImRsgWrFHKJF-x42dE3cMsluGQZBD-ruDvCH-34F-xUwL95U4Sui4n0PxuMb_7n_krdvRsMocdg2Y7_AD369Fh3G2LHqGu2OfZhC-favsOaZ4RFTNbxt1qy_aV4e62iG8LDPk0Ff3lLVr_lb0jRGisWIhvbHf6u4ZDTHKm8L38z09QKwIG priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3daxQxEA-1vvgiFb_Waongm6y9ZLPZRBCpYimCPnnQt5CPiS3IXr3dA_vfO5PdK55U8G3Zj-zuJJmZX2byG8ZexZy9DN7XSptcK-mh9i0eEfWH0FmkRcmq_PJVny3V5_P2fI9tyx3NAhxuhXZUT2q5_vHm18_r9zjh3xHiRHt7nK-Ga0qLlA0qAAQssrnD7kqFSJ1S-WZ3v2hmssaluqTQWtUUxJr20fyjmR1bVSj9b_ND_06n_MM-nR6w-7NjyU-mkfCA7UH_kI2TfvNFqfEBlcRIvcw3A_DLns-kqgNPU8IdJE7rspw4N0sWZJ2AGCbG4wuEq2U_FZWa4Gmm7HzLfc-hZPGVYD0vZLWP2PL007ePZ_VcZ6GOCI7H2rYQdKOilklAC-CNyD6j4xQXKmSZGplisjFDiBJst4hAJG6tCK3Fp1AnPGb7_aqHp4wTvApWC2xCqExhWxMjZAvWtK1JvmKvtxJ1VxOdhkMYQvJ3Rf6O5O9m-VfsAwn95k6iwi4nVuvvbp5ZzndBmozDzaL36buFjV3SHpTJTTI-xIq93HaZw6lD8RDfw2ozOLTMTWEs1BV7MnXhzauaTiEQNKJiZqdzd75l90p_eVHouQU6BRSsfvYfLz5k9-iHabFYiOdsf1xv4AV6OWM4KkP3NzVB_-A priority: 102 providerName: Scholars Portal |
| Title | Psychoactive substance use in patients diagnosed with attention-deficit/hyperactivity disorder: an exploratory study |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/37496681 https://search.proquest.com/docview/2843037146 https://pubmed.ncbi.nlm.nih.gov/PMC10366592 https://doaj.org/article/a7b28fbaa9054a709c7d6ae48f3d8abc |
| Volume | 14 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZJTr2UhqatmzQokFtxvLJlWeqtDQ0hsKWHBnIzeoyahca7xN5D_31nZDtkS0-9GOOnmBmNZjSfPjF27mO0pbM2l0rHXJYWclvjGVF_CBVFWCRU5fKbur6VN3f13R5T81qYBNr3bnXR_Xq46Fb3CVu5efDFjBMrvi8vBbpdKgcW-2wfLfRZjp78L425qh5XyGAGZoq46X8TbrKs0ENgRlNWO6NQIuv_V4T5N1Dy2chz9Yq9nEJG_nls2iHbg-41G0bPZZO74j12_4H0x7c98FXHJ7rUnocRSgeB04wrJzbNhG_MAxB3xFDcYyKaVkrRJhI8TGScn7jtOCR8XirD80RDe8Rur77-uLzOpx0Uco9p75CbGpyqpFdlEFADWC2ijRgS-YV0sQxVGXwwPoLzJZhm4YHo2WrhaoNvYW9_ww66dQfvGKfEyRkl8BNCRirIau8hGjC6rnWwGfs4S7TdjEQZLSYYJP82yb8l-beT_DP2hYT-9CSRXKcL68ef7aTq1jau1BENyWBcaZuF8U1QFqSOVdDW-YydzSprsVNQpcN2sN72LY65VeIiVBl7O6rw6VdVIzHF0yJjeke5O23ZvYN2mIi3Z7t7__-vHrMXJAeaHRbihB0Mj1v4gGHN4E7TdAAel1KfJov-A2CpAV4 |
| link.rule.ids | 230,315,730,783,787,867,888,2109,24330,27936,27937,53804,53806 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKOcClgHilvIzEDWUT5-HY3KCiWqBbcWhFb5afdAXNrprsAX49M05SdSsucIviOHE84_GM5_NnQt7YEHRhtE4rLkJaFdqnuoYrpP5gPDCXR1Tl4pjPT6vPZ_XZDuHTXpgI2rdmOWt_Xsza5XnEVq4vbDbhxLKviwMGZhfTgdktchsGbF5di9KjBcZZl9fDHhmIwWQW1t0vRE4WJdgIiGmKcmseinT9f_Mxb0Ilr809h_fIt6nVA-Tkx2zTm5n9fYPQ8d9_6z7ZG91R-n4of0B2fPuQ9INV1NEU0g5MS4-6QTedp8uWjlSsHXUDTM87iqu5FJk6I3YydR55KfrsHILcuAsLD6igbiT6fEd1S33E_sUUP40Ut4_I6eHHk4N5Op7OkFoIqftU1t7wsrK8cMzX3mvBgg7gbtm8MqFwZeGskzZ4Ywsvm9x6pH6rmakl1AJL8pjstqvWPyUUgzIjOYNXsCpgsldY64P0UtS1cDohbydZqfVAwqEgeEHJqihZhZJVo2QT8gHFefUkEmjHG6vL72rsb6UbU4gASirBZ9VNLm3juPaVCKUT2tiEvJ6UQcGAwyyKbv1q0ymYz8vIc8gT8mRQjqtPlU0F4aNgCRFbarPVlu0SUIZI6j0Jf___q74id-YniyN19On4yzNyF_sEV6EZe052-8uNfwHuU29exrHyB3LaIbY |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSIgLFPEKUDASN5RNnIdjc6OFVXm06oFKlThYfozbFTS7arIH-PUdO0nVrTj1FiV24njG4xnP58-EvLfe68JonVZc-LQqNKS6xqtA_cG4Zy6PqMqDQ75_XH07qU9GVGU3wipbaxaz9s_5rF2cRWzl6txmE04sOzrYY2h2QzowWzmf3SX3cNDm_FqkHq1wmHl5PeyTwThMZn7V_Q3oyaJEO4FxTVFuzEWRsv9_fuZNuOS1-Wf-iPyaWj7ATn7P1r2Z2X83SB1v92vb5OHoltJPQ5nH5A60T0g_WEcdTSLt0MT0QUfougO6aOlIydpRN8D1wNGwqksDY2fEUKYOAj9Fn51hsBt3Y4WDKqgbCT8_Ut1SiBjAmOqnker2KTmef_m5t5-OpzSkFkPrPpU1GF5WlheOQQ2gBfPao9tl88r4wpWFs05aD8YWIJvcQqCAq5mpJdZCi_KMbLXLFl4QGoIzIznDV7DKh6SvsBa8BCnqWjidkA-TvNRqIONQGMQE6aooXRWkq0bpJmQ3iPSqZCDSjjeWF6dq7HOlG1MIj8oq0XfVTS5t47iGSvjSCW1sQt5NCqFw4IVsim5hue4Uzutl5DvkCXk-KMjVp8qmwjBSsISIDdXZaMvmE1SISO49KcDL21d9S-4ffZ6rH18Pv78iD0KXhMVoxl6Trf5iDTvoRfXmTRwul0sXJDY |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Psychoactive+substance+use+in+patients+diagnosed+with+attention-deficit%2Fhyperactivity+disorder%3A+an+exploratory+study&rft.jtitle=Frontiers+in+psychiatry&rft.au=Wi%C4%99ckiewicz%2C+Gniewko&rft.au=Stok%C5%82osa%2C+Iga&rft.au=Stok%C5%82osa%2C+Maciej&rft.au=Wi%C4%99ckiewicz%2C+W%C5%82odzimierz&rft.date=2023-07-11&rft.issn=1664-0640&rft.eissn=1664-0640&rft.volume=14&rft.spage=1184023&rft.epage=1184023&rft_id=info:doi/10.3389%2Ffpsyt.2023.1184023&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-0640&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-0640&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-0640&client=summon |